Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI PWR FOR SUSP 125MG/5ML | 125MG | POWDER FOR SUSPENSION | Resolved | 2017-06-26 | 2018-09-09 | 13967 |
| APO-AMOXI PWR FOR SUSP 250MG/5ML | 250MG | POWDER FOR SUSPENSION | Resolved | 2018-03-27 | 2018-04-24 | 44099 |
| APO-AMOXI PWR FOR SUSP 250MG/5ML | 250MG | POWDER FOR SUSPENSION | Resolved | 2017-11-13 | 2018-01-31 | 29028 |
| APO-AMOXI PWR FOR SUSP 250MG/5ML | 250MG | POWDER FOR SUSPENSION | Resolved | 2019-01-03 | 2019-02-01 | 71103 |
| APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-12 | 2024-03-01 | 215964 |
| APO-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-19 | 2024-02-23 | 216681 |
| APO-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-09-22 | 2023-11-17 | 204987 |
| APO-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-23 | 2023-03-23 | 179437 |
| APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-04-06 | 184103 |
| APO-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-23 | 2023-03-23 | 185474 |
| APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2025-01-30 | 2025-03-13 | 249092 |
| APO-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2025-02-13 | 2025-03-13 | 250325 |
| APO-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2025-02-27 | 2025-03-13 | 251358 |
| APO-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2025-02-27 | 2025-03-13 | 251361 |
| APO-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2025-04-24 | 2025-04-24 | 255716 |
| APO-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-14 | 2023-04-06 | 171836 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 55 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-04-07 | 2017-12-11 | 5888 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-05-30 | 2024-09-27 | 229161 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-04-12 | 2024-10-04 | 225101 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |